(Q34521237)

2 August 2017

The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro (English)

1 reference

2 August 2017

0 references

1 reference

S Migliaccio

9

0 references

author name string

A Taranta

1

1 reference

2 August 2017

M Brama

2

1 reference

2 August 2017

A Teti

3

1 reference

2 August 2017

V De luca

4

1 reference

2 August 2017

R Scandurra

5

1 reference

2 August 2017

G Spera

6

1 reference

2 August 2017

D Agnusdei

7

1 reference

2 August 2017

J D Termine

8

1 reference

2 August 2017

1 February 2002

1 reference

2 August 2017

1 reference

2 August 2017

30

1 reference

2 August 2017

368-376

1 reference

2 August 2017

2

1 reference

Tartronates: a new generation of drugs affecting bone metabolism

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

A new method to isolate large numbers of rabbit osteoclasts and osteoclast-like cells: application to the characterization of serum response element binding proteins during osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

The contribution of trabecular architecture to cancellous bone quality

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Evidence of estrogen receptors in normal human osteoblast-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Heterogeneity of binding sites and bioeffects of raloxifene on the human leukemic cell line FLG 29.1.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Stimulation of creatine kinase specific activity in human osteoblast and endometrial cells by estrogens and anti-estrogens and its modulation by calciotropic hormones

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Raloxifene is a tissue-selective agonist/antagonist that functions through the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Expression of colony-stimulating factor-1 in vivo during the formation of osteoclasts.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

The bone-specific estrogen centchroman inhibits osteoclastic bone resorption in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Biphasic effect of estrogen on neuronal constitutive nitric oxide synthase via Ca(2+)-calmodulin dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Osteoporosis and the risk of hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Estrogens modulate the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Expression of estrogen receptor-alpha in cells of the osteoclastic lineage

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Estrogen regulation of gene expression in osteoblasts and osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Melanoma cells stimulate osteoclastogenesis, c-Src expression and osteoblast cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Involutional osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Human bone cellsin vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

The actions and interactions of sex steroids and growth factors/cytokines on the skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Osteoclast Isolation: New Developments and Methods

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Mechanism of action of estrogen on cancellous bone balance in tibiae of ovariectomized growing rats: inhibition of indices of formation and resorption

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Expression and localization of estrogen receptor-beta in murine and human bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Estrogen Treatment Prevents Osteopenia and Depresses Bone Turnover in Ovariectomized Rats*

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2801%2900685-8

7 January 2021

10.1016/S8756-3282(01)00685-8

Identifiers

DOI

1 reference

2 August 2017

1 reference